BRIEF-CTI Biopharma says reacquired worldwide rights to develop, commercialize Pacritinib By: Reuters: Company News October 24, 2016 at 06:28 AM EDT * Says has reacquired worldwide rights for development and commercialization of Pacritinib Read More >> Related Stocks: Baxter International